BlackRock, Inc. 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-19 2:40 pm Purchase |
2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
BlackRock Inc. BLK |
5,786,527 17.700% |
55,222![]() (+0.96%) |
Filing |
2023-01-30 09:55 am Purchase |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
BlackRock Inc. BLK |
5,731,305 17.100% |
99,645![]() (+1.77%) |
Filing |
2022-01-28 2:07 pm Sale |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
BlackRock Inc. BLK |
5,631,660 16.300% |
-244,012![]() (-4.15%) |
Filing |
2021-03-09 6:33 pm Purchase |
2021-02-28 | 13G | Collegium Pharmaceutical, Inc. COLL |
BlackRock Inc. BLK |
5,875,672 16.900% |
3,037,455![]() (+107.02%) |
Filing |
2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
BlackRock Inc. BLK |
2,838,217 8.200% |
272,290![]() (+10.61%) |
Filing |